Interstitial fluid lipoproteins

Current Opinion in Lipidology

Volumn 24, Issue 4, 2013, Pages 327-331

  Lundberg, Johanna ^a,b   Rudling, Mats ^a,b   Angelin, Bo ^a,b  

^a Metabolism Unit   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Cellular matrix; Interstitium; Lipoproteins; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ATHEROSCLEROSIS; CHEMICAL COMPOSITION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; EXTRACELLULAR MATRIX; HUMAN; HYPERLIPOPROTEINEMIA; INTERSTITIAL FLUID; INTERSTITIUM; LIPOPROTEIN METABOLISM; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; BIOLOGICAL TRANSPORT; CHOLESTEROL; EXTRACELLULAR FLUID; HUMANS; HYPERLIPOPROTEINEMIAS; LIPOPROTEINS;

EID: 84880637670     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283630846     Document Type: Review

References (29)

1. Reichl D, Myant NB, Brown MS, Goldstein JL. Biologically active low density lipoprotein in human peripheral lymph. J Clin Invest 1978; 61:64-71.
2. Wiig H, Swartz M. Interstitial fluid and lymph formation and transport: physiological regulation and roles in inflammation and cancer. Physiol Rev 2012; 92:1005-1060.
3. Kinmonth JB. Lymphangiography in clinical surgery and particularly in the treatment of lympoedema. Ann R Coll Surg Engl 1954; 15:300-310.
4. Engeset A, Hager B, Nesheim A, Kolbenstvedt A. Studies on human peripheral lymph. I. Sampling method. Lymphology 1973; 6:1-5.
5. Kiistala U. Suction blister device for separation of viable epidermis from dermis. J Invest Dermatol 1968; 50:129-137.
6. Reichl D, Simons LA, Myant NB, et al. The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin Sci Mol Med 1973; 45:313-329.
7. Reichl D, Postiglione A, Myant NB, et al. Observations on the passage of apoproteins from plasma lipoproteins into peripheral lymph in two men. Clin Sci Mol Med 1975; 49:419-426.
8. Vermeer BJ, Reman FC, van Gent CM. The determination of lipids and proteins in suction blister fluid. J Invest Dermatol 1979; 73:303-305.
9. Reichl D, Myant NB, Pflug JJ. Concentration of lipoproteins containing apolipoprotein B in human peripheral lymph. Biochimica et Biophysica Acta 1977; 489:98-105.
10. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Lipid and apolipoprotein concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in prenodal leg lymph of fasted humans. Associations with plasma concentrations in normal subjects, lipoprotein lipase deficiency, and LCAT deficiency. J Lipid Res 2000; 41:1317-1327.
11. Reichl D, Pflug JJ. The concentration of apolipoprotein A-I in human peripheral lymph. Biochimica et Biophysica Acta 1982; 710:456-463.
12. Reichl D, Rudra DN, Pflug J. The concentration of apolipoprotein A-II in human peripheral lymph. Biochim Biophys Acta 1989; 1006:246-249.
13. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol 2000; 20:2148-2155.
14. Vessby B, Gustafson S, Chapman MJ, et al. Lipoprotein composition of human suction-blister interstitial fluid. J Lipid Res 1987; 28:629-641.
15. Gustafson S, Vessby B, Ostlund-Lindqvist AM. Serum and interstitial fluid apolipoprotein E levels in the healthy and in hyperlipoproteinemia type III as studied by radioimmunoassay. Clin Chim Acta 1985; 151:49-59.
16. Tamsma JT, Beverdam FH, Leuven JA, Lemkes HH. Decreased interstitial apolipoprotein A-I levels in IDDM patients with diabetic nephropathy. Diabetes 1995; 44:501-505.
17. Parini P, Johansson L, Bröijersen A, et al. Lipoprotein profiles in plasma and interstitial fluid analyzed with an automated gel-filtration system. Eur J Clin Invest 2006; 36:98-104.
18. Luc G, Majd Z, Poulain P, et al. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction. Atherosclersosis 1996; 127:131-137.
19. Dabbagh AJ, Frei B. Human suction blister interstitial fluid prevents metal iondependent oxidation of low density lipoprotein by macrophages and in cellfree systems. J Clin Invest 1995; 96:1958-1966.
20. Rudra DN, Myant NB, Pflug JJ, Reichl D. The distribution of cholesterol and apoprotein A-I between the lipoproteins in plasma and peripheral lymph from normal human subjects. Atherosclerosis 1984; 53:297-308.
21. Reichl D, Myant NB, Rudra DN, Pflug JJ. Evidence for the presence of tissuefree cholesterol in low density and high density lipoproteins of human peripheral lymph. Atherosclerosis 1980; 37:489-495.
22. Reichl D, Hathaway CB, Sterchi JM, Miller NE. Lipoproteins of human peripheral lymph. Apolipoprotein AI-containing lipoprotein with alpha-2-electrophoretic mobility. Eur J Clin Invest 1991; 21:638-643.
23. Nanjee MN, Cooke CJ, Wong JS, et al. Composition and ultrastructure of size subclasses of normal human peripheral lymph lipoproteins: quantification of cholesterol uptake by HDL in tissue fluids. J Lipid Res 2001; 42:639-648.
24. Nanjee MN, Cooke CJ, Garvin R, et al. Intravenous apoA-I/lecithin discs increase prebeta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans. J Lipid Res 2001; 42:1586-1593.
25. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans. Circulation 1999; 100:594-598.
26. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. J Am Med Assoc (JAMA) 2003; 290:2292-2300.
27. Miller NE, Olszewski WL, Hattori H, et al. Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid. Am J Physiol 2013; 304:E321-328.
28. Lim HY, Thiam CH, Yeo KP, et al. Lymphatic vessels are essential for the removal of cholesterol from peripheral tissues by SR-BI-mediated transport of HDL. Cell Metabolism 2013; 17:671-684.
29. Tannock LR, King VL. Proteoglycan mediated lipoprotein retention: a mechanism of diabetic atherosclerosis. Rev Endocr Metab Disord 2008; 9:289-300.